PARGY-LAD
Chemical compound
From Wikipedia, the free encyclopedia
PARGY-LAD, also known as 6-propynyl-6-nor-LSD or 6-propargyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[3]
Other namesPARGYLAD; PROPARGYL-LAD; PROPARGYLLAD; 6-Propynyl-6-nor-LSD; N,N-Diethyl-6-propargyl-6-norlysergamide; N,N-Diethyl-6-(prop-2-yn-1-yl)-9,10-didehydroergoline-8β-carboxamide
Legal status
- DE: NpSG (Industrial and scientific use only)
- UK: Under Psychoactive Substances Act
- Illegal in France[2]
 | |
 | |
| Clinical data | |
|---|---|
| Other names | PARGYLAD; PROPARGYL-LAD; PROPARGYLLAD; 6-Propynyl-6-nor-LSD; N,N-Diethyl-6-propargyl-6-norlysergamide; N,N-Diethyl-6-(prop-2-yn-1-yl)-9,10-didehydroergoline-8β-carboxamide |
| Routes of administration | Oral[1] |
| Drug class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H25N3O |
| Molar mass | 347.462 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Use and effects
PARGY-LAD is hallucinogenic similarly to LSD, but is considerably less potent than LSD, with a dose of 160 μg producing only mild effects, and 500 μg required for full activity.[1]
Interactions
Chemistry
History
PARGY-LAD was developed by David E. Nichols and colleagues at Purdue University in the 1980s[3] and is described by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved).[1]